|
1
|
Feng Z, Wu J, Lu Y, Chan YT, Zhang C, Wang
D, Luo D, Huang Y, Feng Y and Wang N: Circulating tumor cells in
the early detection of human cancers. Int J Biol Sci. 18:3251–3265.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang W, Xu F, Yao J, Mao C, Zhu M, Qian
M, Hu J, Zhong H, Zhou J, Shi X and Chen Y: Single-cell metabolic
fingerprints discover a cluster of circulating tumor cells with
distinct metastatic potential. Nat Commun. 14:24852023. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
El-Kenawi A, Hänggi K and Ruffell B: The
immune microenvironment and cancer metastasis. Cold Spring Harb
Perspect Med. 10:a0374242020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pereira-Veiga T, Schneegans S, Pantel K
and Wikman H: Circulating tumor cell-blood cell crosstalk: Biology
and clinical relevance. Cell Rep. 40:1112982022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schmidt C: The benefits of immunotherapy
combinations. Nature. 552:S67–S69. 2017. View Article : Google Scholar
|
|
6
|
Brozos-Vázquez EM, Díaz-Peña R,
García-González J, León-Mateos L, Mondelo-Macía P, Peña-Chilet M
and López-López R: Immunotherapy in nonsmall-cell lung cancer:
current status and future prospects for liquid biopsy. Cancer
Immunol Immunother. 70:1177–1188. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu H, Zuo Y, Gao S, Liu Y, Liu T, He S,
Wang M, Hu L, Li C and Yu Y: Circulating tumor cell phenotype
detection and epithelial-mesenchymal transition tracking based on
dual biomarker co-recognition in an integrated PDMS chip. Small.
20:e23103602024. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhong X, Zhang H, Zhu Y, Liang Y, Yuan Z,
Li J, Li J, Li X, Jia Y, He T, et al: Circulating tumor cells in
cancer patients: Developments and clinical applications for
immunotherapy. Mol Cancer. 19:152020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Singh B, Arora S, D'Souza A, Kale N, Aland
G, Bharde A, Quadir M, Calderón M, Chaturvedi P and Khandare J:
Chemo-specific designs for the enumeration of circulating tumor
cells: Advances in liquid biopsy. J Mater Chem B. 9:2946–2978.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ye Q, Ling S, Zheng S and Xu X: Liquid
biopsy in hepatocellular carcinoma: Circulating tumor cells and
circulating tumor DNA. Mol Cancer. 18:1142019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li M, Li L, Zheng J, Li Z, Li S, Wang K
and Chen X: Liquid biopsy at the frontier in renal cell carcinoma:
recent analysis of techniques and clinical application. Mol Cancer.
22:372023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shuai Y, Ma Z, Ju J, Wei T, Gao S, Kang Y,
Yang Z, Wang X, Yue J and Yuan P: Liquid-based biomarkers in breast
cancer: Looking beyond the blood. J Transl Med. 21:8092023.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jou HJ, Ho HC, Huang KY, Chen CY, Chen SW,
Lo PH, Huang PW, Huang CE and Chen M: Isolation of TTF-1 positive
circulating tumor cells for single-cell sequencing by using an
automatic platform based on microfluidic devices. Int J Mol Sci.
23:151392022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu CM, Tang M, Feng J, Xia HF, Wu LL, Pang
DW, Chen G and Zhang ZL: A liquid biopsy-guided drug release system
for cancer theranostics: Integrating rapid circulating tumor cell
detection and precision tumor therapy. Lab Chip. 20:1418–1425.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ashworth T: A case of cancer in which
cells similar to those in the tumours were seen in the blood after
death. Aust Med J. 14:146–147. 1869.
|
|
16
|
Nasr MM and Lynch CC: How circulating
tumor cluster biology contributes to the metastatic cascade: From
invasion to dissemination and dormancy. Cancer Metastasis Rev.
42:1133–1146. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Smit DJ, Pantel K and Jücker M:
Circulating tumor cells as a promising target for individualized
drug susceptibility tests in cancer therapy. Biochem Pharmacol.
188:1145892021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peck K, Sher YP, Shih JY, Roffler SR, Wu
CW and Yang PC: Detection and quantitation of circulating cancer
cells in the peripheral blood of lung cancer patients. Cancer Res.
58:2761–2765. 1998.PubMed/NCBI
|
|
19
|
Cristofanilli M, Budd GT, Ellis MJ,
Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ,
Terstappen LW and Hayes DF: Circulating tumor cells, disease
progression, and survival in metastatic breast cancer. N Engl J
Med. 351:781–791. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Magri V, Marino L, Nicolazzo C, Gradilone
A, De Renzi G, De Meo M, Gandini O, Sabatini A, Santini D, Cortesi
E and Gazzaniga P: Prognostic role of circulating tumor cell
trajectories in metastatic colorectal cancer. Cells. 12:11722023.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Allard WJ, Matera J, Miller MC, Repollet
M, Connelly MC, Rao C, Tibbe AG, Uhr JW and Terstappen LW: Tumor
cells circulate in the peripheral blood of all major carcinomas but
not in healthy subjects or patients with nonmalignant diseases.
Clin Cancer Res. 10:6897–6904. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nagrath S, Sequist LV, Maheswaran S, Bell
DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky
A, et al: Isolation of rare circulating tumour cells in cancer
patients by microchip technology. Nature. 450:1235–1239. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hartmann C, Patil R, Lin CP and Niedre M:
Fluorescence detection, enumeration and characterization of single
circulating cells in vivo: Technology, applications and future
prospects. Phys Med Biol. 63:01TR012017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tang M, Xia HF, Xu CM, Feng J, Ren JG,
Miao F, Wu M, Wu LL, Pang DW, Chen G and Zhang ZL: Magnetic chip
based extracorporeal circulation: A new tool for circulating tumor
cell in vivo detection. Anal Chem. 91:15260–15266. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hazra RS, Kale N, Boyle C, Molina KB,
D'Souza A, Aland G, Jiang L, Chaturvedi P, Ghosh S, Mallik S, et
al: Magnetically-activated, nanostructured cellulose for efficient
capture of circulating tumor cells from the blood sample of head
and neck cancer patients. Carbohydr Polym. 323:1214182024.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Q, Zhang X, Xie P and Zhang W:
Liquid biopsy: An arsenal for tumour screening and early diagnosis.
Cancer Treat Rev. 129:1027742024. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ghassemi P, Ren X, Foster BM, Kerr BA and
Agah M: Post-enrichment circulating tumor cell detection and
enumeration via deformability impedance cytometry. Biosens
Bioelectron. 150:1118682020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nikanjam M, Kato S and Kurzrock R: Liquid
biopsy: Current technology and clinical applications. J Hematol
Oncol. 15:1312022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kowalik A, Kowalewska M and Góźdź S:
Current approaches for avoiding the limitations of circulating
tumor cells detection methods-implications for diagnosis and
treatment of patients with solid tumors. Transl Res. 185:58–84.e15.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
You Q, Peng J, Chang Z, Ge M, Mei Q and
Dong WF: Specific recognition and photothermal release of
circulating tumor cells using near-infrared light-responsive 2D
MXene simplenanosheets@hydrogel
membranes. Talanta. 235:1227702021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang K, Wang X, Pan Q and Zhao B: Liquid
biopsy techniques and pancreatic cancer: diagnosis, monitoring, and
evaluation. Mol Cancer. 22:1672023. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin D, Shen L, Luo M, Zhang K, Li J, Yang
Q, Zhu F, Zhou D, Zheng S, Chen Y and Zhou J: Circulating tumor
cells: Biology and clinical significance. Signal Transduct Target
Ther. 6:4042021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu Y, Zhang Y, Chen Y, Wang X, Kang K, Zhu
N, Wu Y and Yi Q: Floating immunomagnetic microspheres for highly
efficient circulating tumor cell isolation under facile magnetic
manipulation. ACS Sens. 8:1858–1866. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yeo D, Kao S, Gupta R, Wahlroos S, Bastian
A, Strauss H, Klemm V, Shrestha P, Ramirez AB, Costandy L, et al:
Accurate isolation and detection of circulating tumor cells using
enrichment-free multiparametric high resolution imaging. Front
Oncol. 13:11412282023. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Labib M and Kelley SO: Circulating tumor
cell profiling for precision oncology. Mol Oncol. 15:1622–1646.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen J, Li D, Zhou C, Zhu Y, Lin C, Guo L,
Le W, Gu Z and Chen B: Principle superiority and clinical
extensibility of 2D and 3D charged nanoprobe detection platform
based on electrophysiological characteristics of circulating tumor
cells. Cells. 12:3052023. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Khan T, Becker TM, Po JW, Chua W and Ma Y:
Single-circulating tumor cell whole genome amplification to unravel
cancer heterogeneity and actionable biomarkers. Int J Mol Sci.
23:83862022. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dianat-Moghadam H, Azizi M, Eslami S Z,
Cortés-Hernández LE, Heidarifard M, Nouri M and Alix-Panabières C:
The role of circulating tumor cells in the metastatic cascade:
Biology, technical challenges, and clinical relevance. Cancers
(Basel). 12:8672020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hyun KA and Jung HI: Advances and critical
concerns with the microfluidic enrichments of circulating tumor
cells. Lab Chip. 14:45–56. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shimmyo N, Furuhata M, Yamada M, Utoh R
and Seki M: Process simplification and structure design of
parallelized microslit isolator for physical property-based capture
of tumor cells. Analyst. 147:1622–1630. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Huang Q, Wang FB, Yuan CH, He Z, Rao L,
Cai B, Chen B, Jiang S, Li Z, Chen J, et al: Gelatin
nanoparticle-coated silicon beads for density-selective capture and
release of heterogeneous circulating tumor cells with high purity.
Theranostics. 8:1624–1635. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tamminga M, Andree KC, Hiltermann TJN,
Jayat M, Schuuring E, van den Bos H, Spierings DCJ, Lansdorp PM,
Timens W, Terstappen LWMM and Groen HJM: Detection of circulating
tumor cells in the diagnostic leukapheresis product of
non-small-cell lung cancer patients comparing
cellsearch® and ISET. Cancers (Basel). 12:8962020.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Barr J, Chudasama D, Rice A, Karteris E
and Anikin V: Lack of association between Screencell-detected
circulating tumour cells and long-term survival of patients
undergoing surgery for non-small cell lung cancer: A pilot clinical
study. Mol Clin Oncol. 12:191–195. 2020.PubMed/NCBI
|
|
44
|
Ferreira MM, Ramani VC and Jeffrey SS:
Circulating tumor cell technologies. Mol Oncol. 10:374–394. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang Y, Wang B, Cai J, Yang Y, Tang C,
Zheng X, Li H and Xu F: Enrichment and separation technology for
evaluation of circulating tumor cells. Talanta. 282:1270252025.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Harouaka RA, Zhou MD, Yeh YT, Khan WJ, Das
A, Liu X, Christ CC, Dicker DT, Baney TS, Kaifi JT, et al: Flexible
micro spring array device for high-throughput enrichment of viable
circulating tumor cells. Clin Chem. 60:323–333. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gkountela S, Castro-Giner F, Szczerba BM,
Vetter M, Landin J, Scherrer R, Krol I, Scheidmann MC, Beisel C,
Stirnimann CU, et al: Circulating tumor cell clustering shapes DNA
methylation to enable metastasis seeding. Cell. 176:98–112.e14.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kurma K, Eslami-S Z, Alix-Panabières C and
Cayrefourcq L: Liquid biopsy: Paving a new avenue for cancer
research. Cell Adh Migr. 18:1–26. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Jia Y, Xu H, Li Y, Wei C, Guo R, Wang F,
Wu Y, Liu J, Jia J, Yan J, et al: A Modified ficoll-paque gradient
method for isolating mononuclear cells from the peripheral and
umbilical cord blood of humans for biobanks and clinical
laboratories. Biopreserv Biobank. 16:82–91. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
He S, Wei J, Ding L, Yang X and Wu Y:
State-of-the-arts techniques and current evolving approaches in the
separation and detection of circulating tumor cell. Talanta.
239:1230242022. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhang Y, Li Y and Tan Z: A review of
enrichment methods for circulating tumor cells: From single
modality to hybrid modality. Analyst. 146:7048–7069. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Peeters DJ, De Laere B, Van den Eynden GG,
Van Laere SJ, Rothé F, Ignatiadis M, Sieuwerts AM, Lambrechts D,
Rutten A, van Dam PA, et al: Semiautomated isolation and molecular
characterisation of single or highly purified tumour cells from
CellSearch enriched blood samples using dielectrophoretic cell
sorting. Br J Cancer. 108:1358–1367. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhao K, Zhao P, Dong J, Wei Y, Chen B,
Wang Y, Pan X and Wang J: Implementation of an integrated
dielectrophoretic and magnetophoretic microfluidic chip for CTC
isolation. Biosensors (Basel). 12:7572022. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zeinali M, Lee M, Nadhan A, Mathur A,
Hedman C, Lin E, Harouaka R, Wicha MS, Zhao L, Palanisamy N, et al:
High-throughput label-free isolation of heterogeneous circulating
tumor cells and CTC clusters from non-small-cell lung cancer
patients. Cancers (Basel). 12:1272020. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Boya M, Ozkaya-Ahmadov T, Swain BE, Chu
CH, Asmare N, Civelekoglu O, Liu R, Lee D, Tobia S, Biliya S, et
al: High throughput, label-free isolation of circulating tumor cell
clusters in meshed microwells. Nat Commun. 13:33852022. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Fabisiewicz A and Grzybowska E: CTC
clusters in cancer progression and metastasis. Med Oncol.
34:122017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Niu Z, Kozminsky M, Day KC, Broses LJ,
Henderson ML, Patsalis C, Tagett R, Qin Z, Blumberg S, Reichert ZR,
et al: Characterization of circulating tumor cells in patients with
metastatic bladder cancer utilizing functionalized microfluidics.
Neoplasia. 57:1010362024. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Vidlarova M, Rehulkova A, Stejskal P,
Prokopova A, Slavik H, Hajduch M and Srovnal J: Recent advances in
methods for circulating tumor cell detection. Int J Mol Sci.
24:39022023. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Sajay BN, Chang CP, Ahmad H, Khuntontong
P, Wong CC, Wang Z, Puiu PD, Soo R and Rahman AR: Microfluidic
platform for negative enrichment of circulating tumor cells. Biomed
Microdevices. 16:537–548. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Ma S, Zhou M, Xu Y, Gu X, Zou M,
Abudushalamu G, Yao Y, Fan X and Wu G: Clinical application and
detection techniques of liquid biopsy in gastric cancer. Mol
Cancer. 22:72023. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Lopes C, Piairo P, Chícharo A, Abalde-Cela
S, Pires LR, Corredeira P, Alves P, Muinelo-Romay L, Costa L and
Diéguez L: HER2 expression in circulating tumour cells isolated
from metastatic breast cancer patients using a size-based
microfluidic device. Cancers (Basel). 13:44462021. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Chowdhury T, Cressiot B, Parisi C,
Smolyakov G, Thiébot B, Trichet L, Fernandes FM, Pelta J and
Manivet P: Circulating tumor cells in cancer diagnostics and
prognostics by single-molecule and single-cell characterization.
ACS Sens. 8:406–426. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Talasaz AH, Powell AA, Huber DE, Berbee
JG, Roh KH, Yu W, Xiao W, Davis MM, Pease RF, Mindrinos MN, et al:
Isolating highly enriched populations of circulating epithelial
cells and other rare cells from blood using a magnetic sweeper
device. Proc Natl Acad Sci USA. 106:3970–3975. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Shi J, Zhao C, Shen M, Chen Z, Liu J,
Zhang S and Zhang Z: Combination of microfluidic chips and
biosensing for the enrichment of circulating tumor cells. Biosens
Bioelectron. 202:1140252022. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Ahmed MG, Abate MF, Song Y, Zhu Z, Yan F,
Xu Y, Wang X, Li Q and Yang C: Isolation, detection, and
antigen-based profiling of circulating tumor cells using a
size-dictated immunocapture chip. Angew Chem Int Ed Engl.
56:10681–10685. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Liu HY, Koch C, Haller A, Joosse SA, Kumar
R, Vellekoop MJ, Horst LJ, Keller L, Babayan A, Failla AV, et al:
Evaluation of microfluidic ceiling designs for the capture of
circulating tumor cells on a microarray platform. Adv Biosyst.
4:e19001622020. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Kulus M, Farzaneh M, Bryja A, Zehtabi M,
Azizidoost S, Abouali Gale Dari M, Golcar-Narenji A, Ziemak H,
Chwarzyński M, Piotrowska-Kempisty H, et al: Phenotypic transitions
the processes involved in regulation of growth and proangiogenic
properties of stem cells, cancer stem cells and circulating tumor
cells. Stem Cell Rev Rep. 20:967–979. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Gwak H, Park S, Kim J, Lee JD, Kim IS, Kim
SI, Hyun KA and Jung HI: Microfluidic chip for rapid and selective
isolation of tumor-derived extracellular vesicles for early
diagnosis and metastatic risk evaluation of breast cancer. Biosens
Bioelectron. 192:1134952021. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Cortés-Hernández LE, Eslami-S Z,
Costa-Silva B and Alix-Panabières C: Current applications and
discoveries related to the membrane components of circulating tumor
cells and extracellular vesicles. Cells. 10:22212021. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Shahhosseini R, Pakmehr S, Elhami A,
Shakir MN, Alzahrani AA, Al-Hamdani MM, Abosoda M, Alsalamy A,
Mohammadi-Dehcheshmeh M, Maleki TE, et al: Current biological
implications and clinical relevance of metastatic circulating tumor
cells. Clin Exp Med. 25:72024. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Zhu L, Lin H, Wan S, Chen X, Wu L, Zhu Z,
Song Y, Hu B and Yang C: Efficient isolation and phenotypic
profiling of circulating hepatocellular carcinoma cells via a
combinatorial-antibody-functionalized microfluidic synergetic-chip.
Anal Chem. 92:15229–15235. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Stott SL, Hsu CH, Tsukrov DI, Yu M,
Miyamoto DT, Waltman BA, Rothenberg SM, Shah AM, Smas ME, Korir GK,
et al: Isolation of circulating tumor cells using a
microvortex-generating herringbone-chip. Proc Natl Acad Sci USA.
107:18392–18397. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Yoon HJ, Kim TH, Zhang Z, Azizi E, Pham
TM, Paoletti C, Lin J, Ramnath N, Wicha MS, Hayes DF, et al:
Sensitive capture of circulating tumour cells by functionalized
graphene oxide nanosheets. Nat Nanotechnol. 8:735–741. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Sheng W, Ogunwobi OO, Chen T, Zhang J,
George TJ, Liu C and Fan ZH: Capture, release and culture of
circulating tumor cells from pancreatic cancer patients using an
enhanced mixing chip. Lab Chip. 14:89–98. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Rostami P, Kashaninejad N, Moshksayan K,
Saidi MS, Firoozabadi B and Nguyen NT: Novel approaches in cancer
management with circulating tumor cell clusters. Journal of
Science: Advanced Materials and Devices. 4:1–18. 2019.
|
|
76
|
Sun N, Zhang C, Wang J, Yue X, Kim HY,
Zhang RY, Liu H, Widjaja J, Tang H, Zhang TX, et al: Hierarchical
integration of DNA nanostructures and NanoGold onto a microchip
facilitates covalent chemistry-mediated purification of circulating
tumor cells in head and neck squamous cell carcinoma. Nano Today.
49:1017862023. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Kolb HC, Finn MG and Sharpless KB: Click
chemistry: Diverse chemical function from a few good reactions.
Angew Chem Int Ed Engl. 40:2004–2021. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Fachin F, Spuhler P, Martel-Foley JM, Edd
JF, Barber TA, Walsh J, Karabacak M, Pai V, Yu M, Smith K, et al:
Monolithic chip for high-throughput blood cell depletion to sort
rare circulating tumor cells. Sci Rep. 7:109362017. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Kumar T, Soares RRG, Ali Dholey L,
Ramachandraiah H, Aval NA, Aljadi Z, Pettersson T and Russom A:
Multi-layer assembly of cellulose nanofibrils in a microfluidic
device for the selective capture and release of viable tumor cells
from whole blood. Nanoscale. 12:21788–21797. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Cui H, Liu Q, Li R, Wei X, Sun Y, Wang Z,
Zhang L, Zhao XZ, Hua B and Guo SS: ZnO nanowire-integrated
bio-microchips for specific capture and non-destructive release of
circulating tumor cells. Nanoscale. 12:1455–1463. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Dong Z, Wang Y, Xu G, Liu B, Wang Y,
Reboud J, Jajesniak P, Yan S, Ma P, Liu F, et al: Genetic and
phenotypic profiling of single living circulating tumor cells from
patients with microfluidics. Proc Natl Acad Sci USA.
121:e23151681212024. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Chu CH, Liu R, Ozkaya-Ahmadov T, Swain BE,
Boya M, El-Rayes B, Akce M, Bilen MA, Kucuk O and Sarioglu AF:
Negative enrichment of circulating tumor cells from unmanipulated
whole blood with a 3D printed device. Sci Rep. 11:205832021.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Ramirez AB, Bhat R, Sahay D, De Angelis C,
Thangavel H, Hedayatpour S, Dobrolecki LE, Nardone A, Giuliano M,
Nagi C, et al: Circulating tumor cell investigation in breast
cancer patient-derived xenograft models by automated
immunofluorescence staining, image acquisition, and single cell
retrieval and analysis. BMC Cancer. 19:2202019. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Ren F, Fei Q, Qiu K, Zhang Y, Zhang H and
Sun L: Liquid biopsy techniques and lung cancer: diagnosis,
monitoring and evaluation. J Exp Clin Cancer Res. 43:962024.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Koinis F, Zafeiriou Z, Messaritakis I,
Katsaounis P, Koumarianou A, Kontopodis E, Chantzara E, Aidarinis
C, Lazarou A, Christodoulopoulos G, et al: Prognostic role of
circulating tumor cells in patients with metastatic
castration-resistant prostate cancer receiving cabazitaxel: A
prospective biomarker study. Cancers (Basel). 15:45112023.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Eftekhari A, Alipour M, Chodari L, Maleki
Dizaj S, Ardalan M, Samiei M, Sharifi S, Zununi Vahed S, Huseynova
I, Khalilov R, et al: A comprehensive review of detection methods
for SARS-CoV-2. Microorganisms. 9:2322021. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Cieślikowski WA, Budna-Tukan J,
Świerczewska M, Ida A, Hrab M, Jankowiak A, Mazel M, Nowicki M,
Milecki P, Pantel K, et al: Circulating tumor cells as a marker of
disseminated disease in patients with newly diagnosed high-risk
prostate cancer. Cancers (Basel). 12:1602020. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Yang D, Yang X, Li Y, Zhao P, Fu R, Ren T,
Hu P, Wu Y, Yang H and Guo N: Clinical significance of circulating
tumor cells and metabolic signatures in lung cancer after surgical
removal. J Transl Med. 18:2432020. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Lei Y, Tang R, Xu J, Wang W, Zhang B, Liu
J, Yu X and Shi S: Applications of single-cell sequencing in cancer
research: progress and perspectives. J Hematol Oncol. 14:912021.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Kojima M, Harada T, Fukazawa T, Kurihara
S, Touge R, Saeki I, Takahashi S and Hiyama E: Single-cell
next-generation sequencing of circulating tumor cells in patients
with neuroblastoma. Cancer Sci. 114:1616–1624. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Rzhevskiy A, Kapitannikova A, Malinina P,
Volovetsky A, Aboulkheyr Es H, Kulasinghe A, Thiery JP,
Maslennikova A, Zvyagin AV and Ebrahimi Warkiani M: Emerging role
of circulating tumor cells in immunotherapy. Theranostics.
11:8057–8075. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Zhang Y and Zheng J: Functions of immune
checkpoint molecules beyond immune evasion. Adv Exp Med Biol.
1248:201–226. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Kloten V, Lampignano R, Krahn T and
Schlange T: Circulating Tumor Cell PD-L1 expression as biomarker
for therapeutic efficacy of immune checkpoint inhibition in NSCLC.
Cells. 8:8092019. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Kennedy LC, Lu J, Kuehn S, Ramirez AB, Lo
E, Sun Y, U'Ren L, Chow LQM, Chen Z, Grivas P, et al: Liquid biopsy
assessment of circulating tumor Cell PD-L1 and IRF-1 expression in
patients with advanced solid tumors receiving immune checkpoint
inhibitor. Target Oncol. 17:329–341. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Hou W, Zhou X, Yi C and Zhu H: Immune
check point inhibitors and immune-related adverse events in small
cell lung cancer. Front Oncol. 11:6042272021. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Ouyang Y, Liu W, Zhang N, Yang X, Li J and
Long S: Prognostic significance of programmed cell death-ligand 1
expression on circulating tumor cells in various cancers: A
systematic review and meta-analysis. Cancer Med. 10:7021–7039.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Papadaki MA, Messaritakis I, Fiste O,
Souglakos J, Politaki E, Kotsakis A, Georgoulias V, Mavroudis D and
Agelaki S: Assessment of the efficacy and clinical utility of
different circulating tumor cell (CTC) detection assays in patients
with chemotherapy-naïve advanced or metastatic non-small cell lung
cancer (NSCLC). Int J Mol Sci. 22:9252021. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Lin M, Liang SZ, Shi J, Niu LZ, Chen JB,
Zhang MJ and Xu KC: Circulating tumor cell as a biomarker for
evaluating allogenic NK cell immunotherapy on stage IV non-small
cell lung cancer. Immunol Lett. 191:10–15. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Tamminga M, de Wit S, Hiltermann TJN,
Timens W, Schuuring E, Terstappen LWMM and Groen HJM: Circulating
tumor cells in advanced non-small cell lung cancer patients are
associated with worse tumor response to checkpoint inhibitors. J
Immunother Cancer. 7:1732019. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Castello A, Carbone FG, Rossi S, Monterisi
S, Federico D, Toschi L and Lopci E: Circulating tumor cells and
metabolic parameters in NSCLC patients treated with checkpoint
inhibitors. Cancers (Basel). 12:4872020. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Banys-Paluchowski M, Fehm TN, Grimm-Glang
D, Rody A and Krawczyk N: Liquid biopsy in metastatic breast
cancer: Current role of circulating tumor cells and circulating
tumor DNA. Oncol Res Treat. 45:4–11. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Heidrich I, Ačkar L, Mossahebi Mohammadi P
and Pantel K: Liquid biopsies: Potential and challenges. Int J
Cancer. 148:528–545. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Gu X, Huang X, Zhang X and Wang C:
Development and validation of a DNA methylation-related classifier
of circulating tumour cells to predict prognosis and to provide a
therapeutic strategy in lung adenocarcinoma. Int J Biol Sci.
18:4984–5000. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Peng QH, Wang CH, Chen HM, Zhang RX, Pan
ZZ, Lu ZH, Wang GY, Yue X, Huang W and Liu RY: CMTM6 and PD-L1
coexpression is associated with an active immune microenvironment
and a favorable prognosis in colorectal cancer. J Immunother
Cancer. 9:e0016382021. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Wang X, Teng F, Kong L and Yu J: PD-L1
expression in human cancers and its association with clinical
outcomes. Onco Targets Ther. 9:5023–5039. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Yao S, Han Y, Yang M, Jin K and Lan H:
Integration of liquid biopsy and immunotherapy: Opening a new era
in colorectal cancer treatment. Front Immunol. 14:12928612023.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Ju S, Chen C, Zhang J, Xu L, Zhang X, Li
Z, Chen Y, Zhou J, Ji F and Wang L: Detection of circulating tumor
cells: Opportunities and challenges. Biomark Res. 10:582022.
View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Dall'Olio FG, Gelsomino F, Conci N,
Marcolin L, De Giglio A, Grilli G, Sperandi F, Fontana F,
Terracciano M, Fragomeno B, et al: PD-L1 Expression in circulating
tumor cells as a promising prognostic biomarker in advanced
non-small-cell lung cancer treated with immune checkpoint
inhibitors. Clin Lung Cancer. 22:423–431. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Chalfin HJ, Pramparo T, Mortazavi A,
Niglio SA, Schonhoft JD, Jendrisak A, Chu YL, Richardson R, Krupa
R, Anderson AKL, et al: Circulating tumor cell subtypes and T-cell
populations as prognostic biomarkers to combination immunotherapy
in patients with metastatic genitourinary cancer. Clin Cancer Res.
27:1391–1398. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Gu X, Wei S and Lv X: Circulating tumor
cells: From new biological insights to clinical practice. Signal
Transduct Target Ther. 9:2262024. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Pantel K and Alix-Panabières C: Crucial
roles of circulating tumor cells in the metastatic cascade and
tumor immune escape: Biology and clinical translation. J Immunother
Cancer. 10:e0056152022. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Jaiswal S, Jamieson CH, Pang WW, Park CY,
Chao MP, Majeti R, Traver D, van Rooijen N and Weissman IL: CD47 is
upregulated on circulating hematopoietic stem cells and leukemia
cells to avoid phagocytosis. Cell. 138:271–285. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Topalian SL, Drake CG and Pardoll DM:
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor
immunity. Curr Opin Immunol. 24:207–212. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Lian S, Xie X, Lu Y and Jia L: Checkpoint
CD47 function on tumor metastasis and immune therapy. Onco Targets
Ther. 12:9105–9114. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Lian S, Xie R, Ye Y, Lu Y, Cheng Y, Xie X,
Li S and Jia L: Dual blockage of both PD-L1 and CD47 enhances
immunotherapy against circulating tumor cells. Sci Rep. 9:45322019.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Yu Y, Cheng Q, Ji X, Chen H, Zeng W, Zeng
X, Zhao Y and Mei L: Engineered drug-loaded cellular membrane
nanovesicles for efficient treatment of postsurgical cancer
recurrence and metastasis. Sci Adv. 8:eadd35992022. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Terme M, Ullrich E, Aymeric L, Meinhardt
K, Desbois M, Delahaye N, Viaud S, Ryffel B, Yagita H, Kaplanski G,
et al: IL-18 induces PD-1-dependent immunosuppression in cancer.
Cancer Res. 71:5393–5399. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Jacot W, Mazel M, Mollevi C, Pouderoux S,
D'Hondt V, Cayrefourcq L, Bourgier C, Boissiere-Michot F, Berrabah
F, Lopez-Crapez E, et al: Clinical correlations of programmed cell
death ligand 1 status in liquid and standard biopsies in breast
cancer. Clin Chem. 66:1093–1101. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Praharaj PP, Bhutia SK, Nagrath S, Bitting
RL and Deep G: Circulating tumor cell-derived organoids: Current
challenges and promises in medical research and precision medicine.
Biochim Biophys Acta Rev Cancer. 1869:117–127. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Riethdorf S, Fritsche H, Müller V, Rau T,
Schindlbeck C, Rack B, Janni W, Coith C, Beck K, Jänicke F, et al:
Detection of circulating tumor cells in peripheral blood of
patients with metastatic breast cancer: A validation study of the
CellSearch system. Clin Cancer Res. 13:920–928. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Li F, Li J, Yuan Y, Zhang H, Zhang S, Bian
L, Wang T and Jiang Z: A real-world comparison of circulating tumor
cells in breast cancer from China: Novel device, CTC counts and its
overall survival. Heliyon. 10:e292172024. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Liu Z, Fusi A, Klopocki E, Schmittel A,
Tinhofer I, Nonnenmacher A and Keilholz U: Negative enrichment by
immunomagnetic nanobeads for unbiased characterization of
circulating tumor cells from peripheral blood of cancer patients. J
Transl Med. 9:702011. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Seyfoori A, Seyyed Ebrahimi SA, Samandari
M, Samiei E, Stefanek E, Garnis C and Akbari M:
Microfluidic-Assisted CTC isolation and in situ monitoring using
smart magnetic microgels. Small. 19:e22053202023. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Shen MJ, Olsthoorn RCL, Zeng Y, Bakkum T,
Kros A and Boyle AL: Magnetic-activated cell sorting using
coiled-coil peptides: An alternative strategy for isolating cells
with high efficiency and specificity. ACS Appl Mater Interfaces.
13:11621–11630. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Zhang W, Duan X, Zhang Z, Yang Z, Zhao C,
Liang C, Liu Z, Cheng S and Zhang K: Combination of CT and
telomerase+ circulating tumor cells improves diagnosis of small
pulmonary nodules. JCI Insight. 6:e1481822021.PubMed/NCBI
|
|
126
|
Vasantharajan SS, Barnett E, Gray ES,
McCall JL, Rodger EJ, Eccles MR, Munro F, Pattison S and Chatterjee
A: Assessment of a size-based method for enriching circulating
tumour cells in colorectal cancer. Cancers (Basel). 14:34462022.
View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Zhang X, Xie P, Zhang K and Zhang W:
Circulating tumour cell isolation, analysis and clinical
application. Cell Oncol (Dordr). 46:533–544. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Lin E, Cao T, Nagrath S and King MR:
Circulating tumor cells: Diagnostic and therapeutic applications.
Annu Rev Biomed Eng. 20:329–352. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Pantel K and Alix-Panabières C: Liquid
biopsy and minimal residual disease-latest advances and
implications for cure. Nat Rev Clin Oncol. 16:409–424. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Kulasinghe A, Kenny L, Perry C, Thiery JP,
Jovanovic L, Vela I, Nelson C and Punyadeera C: Impact of
label-free technologies in head and neck cancer circulating tumour
cells. Oncotarget. 7:71223–71234. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Ye F, Wechsler J, Bouzidi A, Uzan G and
Naserian S: Fast and efficient isolation of murine circulating
tumor cells using screencell technology for pre-clinical analyzes.
Sci Rep. 14:150192024. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Philippron A, Depypere L, Oeyen S, De
Laere B, Vandeputte C, Nafteux P, De Preter K and Pattyn P:
Evaluation of a marker independent isolation method for circulating
tumor cells in esophageal adenocarcinoma. PLoS One.
16:e02510522021. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Andrikou K, Rossi T, Verlicchi A, Priano
I, Cravero P, Burgio MA, Crinò L, Bandini S, Ulivi P and Delmonte
A: Circulating tumour cells: Detection and application in advanced
non-small cell lung cancer. Int J Mol Sci. 24:160852023. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Çağlayan Arslan Z, Demircan Yalçın Y and
Külah H: Label-free enrichment of MCF7 breast cancer cells from
leukocytes using continuous flow dielectrophoresis.
Electrophoresis. 43:1531–1544. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Sarioglu AF, Aceto N, Kojic N, Donaldson
MC, Zeinali M, Hamza B, Engstrom A, Zhu H, Sundaresan TK, Miyamoto
DT, et al: A microfluidic device for label-free, physical capture
of circulating tumor cell clusters. Nat Methods. 12:685–691. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Zhou W, Zhu C, Shen P, Wang JF, Zhu G, Jia
Y, Wu Y, Wang S, Sun J, Yang F, et al: Hypoxia stimulates
CTC-platelet cluster formation to promote breast cancer metastasis.
IScience. 27:1095472024. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Boyer M, Cayrefourcq L, Garima F,
Foulongne V, Dereure O and Alix-Panabières C: Circulating tumor
cell detection and polyomavirus status in merkel cell carcinoma.
Sci Rep. 10:16122020. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Smit DJ and Pantel K: Circulating tumor
cells as liquid biopsy markers in cancer patients. Mol Aspects Med.
96:1012582024. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Karabacak NM, Spuhler PS, Fachin F, Lim
EJ, Pai V, Ozkumur E, Martel JM, Kojic N, Smith K, Chen PI, et al:
Microfluidic, marker-free isolation of circulating tumor cells from
blood samples. Nat Protoc. 9:694–710. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Sassi A and You L: Microfluidics-based
technologies for the assessment of castration-resistant prostate
cancer. Cells. 13:5752024. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Wei J, Deng W, Weng J, Li M, Lan G, Li X,
Ye L, Wang Y, Liu F, Ou H, et al: Epithelial-mesenchymal transition
classification of circulating tumor cells predicts clinical
outcomes in progressive nasopharyngeal carcinoma. Front Oncol.
12:9884582022. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Lopresti A, Malergue F, Bertucci F,
Liberatoscioli ML, Garnier S, DaCosta Q, Finetti P, Gilabert M,
Raoul JL, Birnbaum D, et al: Sensitive and easy screening for
circulating tumor cells by flow cytometry. JCI Insight.
5:e1281802019. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Kotsifaki A, Maroulaki S and Armakolas A:
Exploring the immunological profile in breast cancer: Recent
advances in diagnosis and prognosis through circulating tumor
cells. Int J Mol Sci. 25:48322024. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Mazard T, Cayrefourcq L, Perriard F,
Senellart H, Linot B, de la Fouchardière C, Terrebonne E, François
E, Obled S, Guimbaud R, et al: Clinical relevance of viable
circulating tumor cells in patients with metastatic colorectal
cancer: The COLOSPOT prospective study. Cancers (Basel).
13:29662021. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Soler A, Cayrefourcq L, Mazel M and
Alix-Panabières C: EpCAM-Independent enrichment and detection of
viable circulating tumor cells using the EPISPOT assay. Methods Mol
Biol. 1634:263–276. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Xu C, Zhang Y, Fan X, Lan X, Ye X and Wu
T: An efficient fluorescence in situ hybridization (FISH)-based
circulating genetically abnormal cells (CACs) identification method
based on Multi-scale MobileNet-YOLO-V4. Quant Imaging Med Surg.
12:2961–2976. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Zhu Y and Lowe AC: Multiplexed
fluorescence in situ hybridization-based detection of circulating
tumor cells: A novel liquid-based technology to facilitate accurate
and early identification of non-small cell lung cancer patients.
Cancer Cytopathol. 128:518–519. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Kruse A, Abdel-Azim N, Kim HN, Ruan Y,
Phan V, Ogana H, Wang W, Lee R, Gang EJ, Khazal S and Kim YM:
Minimal residual disease detection in acute lymphoblastic leukemia.
Int J Mol Sci. 21:10542020. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Zavridou M, Smilkou S, Tserpeli V, Sfika
A, Bournakis E, Strati A and Lianidou E: Development and analytical
validation of a 6-plex reverse transcription droplet digital PCR
assay for the absolute quantification of prostate cancer biomarkers
in circulating tumor cells of patients with metastatic
castration-resistant prostate cancer. Clin Chem. 68:1323–1335.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
De Luca G, Cardinali B, Del Mastro L,
Lastraioli S, Carli F, Ferrarini M, Calin GA, Garuti A, Mazzitelli
C, Zupo S and Dono M: Optimization of a WGA-free molecular
tagging-based NGS protocol for CTCs mutational profiling. Int J Mol
Sci. 21:43642020. View Article : Google Scholar : PubMed/NCBI
|
